Wednesday, 7 August 2019
Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.
By KATIE THOMAS from NYT Health https://ift.tt/2YPZ7N5
FDA: Pricey Drug Approved on Manipulated Data
The FDA approved the gene therapy Zolgensma to treat children with a severe form of spinal muscular atrophy. The drug costs $2.125 million for a one-time treatment, CBS News reported.
from WebMD Health https://ift.tt/2ZFHnVR
One Dead In Atlanta Hotel Legionnaires' Outbreak
Another 61 probable cases of the disease have been identified, according to Nancy Nydam, director of communications at Georgia Department of Public Health, CNN reported.
from WebMD Health https://ift.tt/2YvQsnr
Tuesday, 6 August 2019
Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment
By KATIE THOMAS from NYT Health https://ift.tt/2M3PJn4
